Revision Year: 2017 Publisher: Medochemie Ltd, 1-10 Constantinoupoleos Street, 3011 Limassol, Cyprus
Bysimin 20mg/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear, colourless or almost colourless solution free from visible particles. |
Each 1ml ampoule contains 20 mg hyoscine butylbromide.
Excipient with known effect: Contains less than 1 mmol of sodium (23 mg) per dose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Butylscopolamine |
Butylscopolamine is an antispasmodic agent which relaxes smooth muscle of the organs of the abdominal and pelvic cavities. It is believed to act predominantly on the intramural parasympathetic ganglia of these organs. |
| List of Excipients |
|---|
|
Sodium chloride |
Box containing 5 × 1 ml or 10 × 1 ml type I clear glass ampoules in PVC trays sealed with PE transparent foil.
Not all pack sizes may be marketed.
Medochemie Ltd, 1-10 Constantinoupoleos Street, 3011 Limassol, Cyprus
| Drug | Countries | |
|---|---|---|
| BYSIMIN | Cyprus, Estonia, Croatia, Malta, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
